首页

Zhaoke Ophthalmology’s Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint

2021-08-18

2878

Zhaoke Ophthalmology Announces First Interim Results

2021-08-16

3399

NTC010 Approved by The Hainan Provincial Medical Products Administration for the Import as an Urgently Needed Drug

2021-08-02

2423

Podcast Series Episode 2: Dry Eye Disease prevalence in China and Zhaoke’s potential treatment solution

2021-07-30

2675

Zhaoke Ophthalmology’s IND Application for Phase III Clinical Trial of NVK-002 for Myopia Treatment in China Accepted for Review by CDE

2021-07-16

2136

首页 13 14 15 16 17 尾页

Guangzhou Headquarters

Tel: 020-39062828

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat

Guangzhou Headquarters

Tel: 020-39062888

E-mail: info@zkoph.com

Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou

Hong Kong Headquarters

Tel: (852)23145100

E-mail: info@zkoph.com

Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong

Wechat